about
Evidence of ball-and-chain transport of ferric enterobactin through FepABranched amphiphilic cationic oligopeptides form peptiplexes with DNA: a study of their biophysical properties and transfection efficiency.Crystallization, data collection and phasing of the molybdate-binding protein of the phytopathogen Xanthomonas axonopodis pv. citri.Alzheimer's disease: is a vaccine possible?Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigenMalaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?Structural and physiological analyses of the alkanesulphonate-binding protein (SsuA) of the citrus pathogen Xanthomonas citriDistinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.Complete Genome Sequence of an Atypical Dengue Virus Serotype 2 Lineage Isolated in BrazilMaternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses.Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine modelParenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin VariantBacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action.Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enThe dengue virus non-structural 1 protein: risks and benefits.Protection against HPV-16-Associated Tumors Requires the Activation of CD8+ Effector Memory T Cells and the Control of Myeloid-Derived Suppressor Cells.Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.Bacillus subtilis spores as adjuvants for DNA vaccines.Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.Beyond serotypes and virulence-associated factors: detection of genetic diversity among O153:H45 CFA/I heat-stable enterotoxigenic Escherichia coli strains.Enhanced anti-tumor effect of a gene gun-delivered DNA vaccine encoding the human papillomavirus type 16 oncoproteins genetically fused to the herpes simplex virus glycoprotein D.Bacterial spores as particulate carriers for gene gun delivery of plasmid DNA.Expression and purification of a recombinant adenovirus fiber knob in a baculovirus system.Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules.Antibody-inducing properties of a prototype bivalent herpes simplex virus/enterotoxigenic Escherichia coli DNA vaccine.Electrophoretic characterisation of the outer membrane proteins of Yersinia pestis isolated in north-east Brazil.Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide.Control of the activity of the soluble lytic transglycosylase by the stringent response in Escherichia coli.Epitope specificity of antibodies raised against enterotoxigenic Escherichia coli CFA/I fimbriae in mice immunized with naked DNA.A DNA Vaccine Encoding the Enterohemorrhagic Escherichia coli Shiga-Like Toxin 2 A2 and B Subunits Confers Protective Immunity to Shiga Toxin Challenge in the Murine Model.Immunoglobulin G subclass responses in mice immunized with plasmid DNA encoding the CFA/I fimbria of enterotoxigenic Escherichia coli.New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.Phylogenetic affiliation and ultrastructure of uncultured magnetic bacteria with unusually large magnetosomes.Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10.
P50
Q30159599-4BFA35B2-CBDF-4DBD-A798-DB3D83798805Q30887298-967F126C-F83F-40EF-A9B2-01FB30A6A186Q31033360-07B40CA6-0464-4746-9C34-380359BE0597Q33861011-0BEA602A-0C79-426D-8D17-1FE7CA506E60Q34606478-03F6AC15-ABC6-4BA3-A5BE-F2CFFE4C465AQ34764532-ACA6861B-7AFC-4B98-B5F5-765D25A439B9Q34983659-081DCEDC-51C4-4A95-AA1E-B29137FA4938Q35055048-BFB7EBB7-4A01-41B7-9EFD-514B9C016D97Q35138744-477030DD-8FDA-4A9A-B0D1-E1EBA1EE6244Q35859712-BCB9A632-5FAA-4860-8A24-85902656E636Q36281365-BACBE125-D3C5-4CDC-ADE9-DA7A76EE63D0Q36450329-1D5F0830-2007-4B5B-A4F0-F67B8A2CBF7CQ36978334-9BBAFB93-A47C-45FF-BFAD-338772C11E58Q37144995-4562A741-903D-4F8A-97AF-69592B56EEC2Q37190873-DC008E3D-92E2-49C2-B8A2-FCF5182AB5DEQ37441681-3CE00F7F-A34A-463B-BCBB-BEA8B7164AEAQ37521363-584A5D99-B835-4545-8806-C4A5F8E91207Q37582794-6DF4F163-755C-4577-A02D-F072F5AC90C2Q38179175-CF9FC6BA-D70E-440D-9F3B-9C69C672ADAFQ38768580-AA743F64-A238-4C06-B720-8D194740860EQ38871575-4726C2BF-2226-42A2-ADEA-D8ACDBA4B2DCQ38893653-0463E309-715E-4A97-8BC2-47E98872C8EDQ39099950-3A3C2EE3-A463-4021-A98D-18D04C48DFA8Q39467393-976929D0-2530-4300-A7F4-652FBE372490Q39766780-FCDA5935-9DA4-438B-89E9-B77D92BA747DQ39808283-0233FA61-A335-4DB0-971D-70AA2A60AF08Q39947598-8CBC817F-5F66-44A2-9EE3-4AE57825B93FQ40536840-C5C82A4C-2DC7-4462-AC98-452A4417F5A4Q40670241-AE4C1217-B308-4CDC-8937-E41AAB9524F7Q41513211-3D6AC338-4205-41DA-96D8-29E933A26018Q41822782-31E95359-7C1F-4B8D-8622-21BCC3113193Q42146388-0AC3E57C-799B-46B4-A08E-71BBDBA2A02CQ43994525-EF797038-078A-4DC5-AF5D-CD2EC496C671Q44227808-3BC309F8-8367-4D30-86D5-ED58822CDA3EQ46581368-5A18A3C4-35A4-4529-A3E4-6E68BEE6CC9FQ47711571-ABFC8335-EE9B-415A-95C4-A23CE87E0575Q47878245-4B726457-6274-429F-BCDC-C3118D9C48E4Q47928079-E346FE04-5C17-4B73-BEF5-AFCFA0572B2BQ48039201-5B43C493-DD63-49EB-874B-C8BBF80210BFQ50425077-7779FB83-C528-4376-9877-9753E398DD96
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luis Carlos Ferreira
@ast
Luis Carlos Ferreira
@es
Luis Carlos Ferreira
@nl
Luis Carlos Ferreira
@sl
Luis Carlos de Souza Ferreira
@en
Luis Carlos de Souza Ferreira
@pt
type
label
Luis Carlos Ferreira
@ast
Luis Carlos Ferreira
@es
Luis Carlos Ferreira
@nl
Luis Carlos Ferreira
@sl
Luis Carlos de Souza Ferreira
@en
Luis Carlos de Souza Ferreira
@pt
prefLabel
Luis Carlos Ferreira
@ast
Luis Carlos Ferreira
@es
Luis Carlos Ferreira
@nl
Luis Carlos Ferreira
@sl
Luis Carlos de Souza Ferreira
@en
Luis Carlos de Souza Ferreira
@pt
P106
P1153
35550625500
P21
P31
P39
P496
0000-0002-4883-1693